ALNY vs FDSB · P/E 76, rev $1.29B vs P/E 18, rev $605.0K
Alnylam Pharmaceuticals Inc (ALNY) versus Fifth District Bancorp, Inc. Common Stock (FDSB) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Fifth District Bancorp, Inc. Common Stock (FDSB) is a banks - regional company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported FDSB revenue for 2025-12-31 was $605.0K. Net income was $4.1M. Revenue was down 2.3% from 2024-12-31 to 2025-12-31. FDSB currently screens at market cap $79.3M and trailing P/E 17.5.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. FDSB currently screens at market cap $79.3M and trailing P/E 17.5.
Not investment advice. Open the ALNY and FDSB stock pages for the full models.
Not investment advice.